Main > NewsNP TEMPORussian version
NP TEMPO website
Educational Programs

news subscribe:
 

Contact Information:
Russia, Moscow, 119992 Trubetskaya Str., 8/2

Phone:
+7 (495) 246 11 30
+7 (495) 708 39 54
+7 (495) 708 39 51

Fax: +7 (495) 708 39 50, 708 39 51

E-mail: info@nptemp.ru
      nataliap@nptemp.ru

News


10.02.2006 - Program of the roundable to be held on 15 February

PROGRAM

  The round table in the frame of Biotechnology Entrepreneurial Competition Program

 

The organizer – Non Commercial Partnership “Center of Modern Technology”TEMP”

 

The roundtable will be held on 15 February 2006 at I.M. Sechenov Moscow Medical Academy (Rectorat Building, 4th Floor, Rectorat meeting hall; Trubetskaya Str., 8/2, metro station Frunzenskaya).

 

This event brings together representatives of investment and consulting companies, industry, and experts in the field of biotechnology, pharmacology and medicine and the authors of the best innovational projects of leading biotech organizations of Russia.

 

 

Time

 

9-30 – 10-00

Registration. Welcome coffee/tea

10-00 – 10-10

Opening address

Yu.V. Remnev, TEMPO Deputy Director

10-10 - 10-25

Venture investment

Eu. Zaitsev, member of American Business Association of Russian Professionals AmBAR, Head of Asset Management Company, California, USA

10-25 - 10-40

Regulatory development and its role in Due Diligence

Z. Pitkin, Vice President, Regulatory Affairs and Quality Systems, USA

10-40 - 10-55

Organization of production of the NEITROSTIM preparation on the basis of human recombinant granulocyte colony-stimulating factor for the hemopoiesis correction

State Research Center of Virology & Biotechnology VECTOR

10-55 – 11-10

Development of anticancer adenovirus preparation “CANCEROLYSIN” State Research Center of Virology & Biotechnology VECTOR

11-10 – 11-25

Development of new preparation on a basis of recombinant receptor antagonist of interleukin-1 (ARIL) for treatment of inflammatory, autoimmune, and allergic diseases with aerosol delivery method

State Research Institute of Highly Pure Biopreparations, St.Petersburg

11-25 – 11-40

Larviol ™ - Microbiological preparation against larvae of bloodsucking mosquitoes

Open Joint Stock Company “Institute of Applied Biochemistry and Machine Building ”Biochimmash”

11-40 – 11-55

DEVELOPMENT OF BIOTECHNOLOGY FOR THE PRODUCTION OF ANTI-CANCER PREPARATION PACLITAXEL

Open Joint Stock Company “Institute of Applied Biochemistry and Machine Building ”Biochimmash”

11-55 – 12-10

Organization of pilot production of a selective adsorbent

for atherosclerosis treatment

State Research Institute of Highly Pure Biopreparations, St.Petersburg

12-10 – 12-25

Nanotechnology of immuneactive antimicrobial compositions

State Research Institute of Highly Pure Biopreparations, St.Petersburg

12-25 – 12-40

THE COMBINED WOUND HEALING DRESSINGS

 WITH THE PROPERTIES OF THE ARTIFICIAL SKIN

State Research Institute of Highly Pure Biopreparations, St.Petersburg

12-40 – 12-55

PRODUCTION OF ANTI-SEPTIC PREPARATION “MIRASEPTÒ Open Joint Stock Company “Institute of Applied Biochemistry and Machine Building ”Biochimmash”

13-00 – 14-00

Lunch

14-00 – 14-15

Stentless Aortic Valve Bioprostheses

Pavlov State Medical University of Saint-Petersburg

14-15 – 14-30

Expression of human interferons beta and gamma in the milk of transgenic animals

 

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS

14-30 – 14-45

Multi-epitope recombinant virus-like particle based vaccine for the prophylaxis and treatment of cow milk allergy

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS

14-45 – 15-00

Collagenase-derived fragments of collagen for ulcer treatment

Imtek Ltd./Russian Cardiology Research Center

15-00 – 15-15

Microbicidal gel for prophylaxis and therapy HIV/AIDS and other sexually - transmitted infections (STI) and development of technology of its manufacture

Medical-Biotechnological Center “Vector-T” Ltd.

 

15-15 – 15-30

GMP manufacture of synthetic peptide drugs

State Research Institute of Highly Pure Biopreparations, St.Petersburg

15-30 – 15-45

Development of live trivalent culture influenza vaccine

State Research Center of Virology & Biotechnology VECTOR

15-45 – 16-00

Coffee break

16-00 – 16-15

Novel synthetic peptide immunomodulators

State Research Institute of Highly Pure Biopreparations, St.Petersburg

16-15 – 16-30

Development of a new method for chronic viral hepatitis C immunotherapy using human recombinant interleukin-1 beta

State Research Institute of Highly Pure Biopreparations, St.Petersburg

16-30 – 16-45

The establishing of TB-test collection production for speeded up identification of the Mycobacterium tuberculosis antibiotic resistance

State Research Center of Applied Microbiology & Biotechnology, Obolensk

16-45 – 17-00

Concluding remarks

Yu.V. Remnev, TEMPO Deputy Director

 


âñå íîâîñòè
© Center of Modern Medical Technology TEMPO, 2005
Making site and multimedia presentation - BIAT